Results 21 to 30 of about 10,858,974 (235)

Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma. [PDF]

open access: yesAm J Clin Dermatol, 2017
Many mammalian viruses have properties that can be commandeered for the treatment of cancer. These characteristics include preferential infection and replication in tumor cells, the initiation of tumor cell lysis, and the induction of innate and adaptive anti-tumor immunity. Furthermore, viruses can be genetically engineered to reduce pathogenicity and
Bommareddy PK   +3 more
europepmc   +3 more sources

Successful treatment of in-transit metastatic melanoma with combination intralesional T-VEC and topical imiquimod immunotherapy. [PDF]

open access: yesJ Immunother Cancer
In-transit metastases of malignant melanoma pose a significant clinical challenge, particularly in patients with contraindications to systemic therapies. While surgical excision and systemic immunotherapies remain standard treatments, localized therapies such as intralesional talimogene laherparepvec (T-VEC) and topical imiquimod, which stimulate tumor-
Lenga M   +7 more
europepmc   +4 more sources

Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma. [PDF]

open access: yesCancers (Basel), 2022
SIMPLE SUMMARY: Since T-VEC is already approved for treatment of melanoma, its promising efficacy shown here also for NUT carcinoma (NC) cell lines may create a rapid transition to individual treatments as well as clinical trials in NC patients. The idea
Ohnesorge PV   +11 more
europepmc   +2 more sources

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany. [PDF]

open access: yesJ Immunother Cancer, 2021
Background Talimogene laherparepvec (T-VEC) is a licensed therapy for use in melanoma patients of stage IIIB-IVM1a with injectable, unresectable metastatic lesions in Europe.
Ressler JM   +15 more
europepmc   +2 more sources

T-VEC: a tool for developing critical systems [PDF]

open access: yesProceedings of 11th Annual Conference on Computer Assurance. COMPASS '96, 2002
This paper describes the specification-based testing and analysis tools, and associated processes, that were used to develop and certify safety-critical avionics systems in an industrial organization. These tools comprise an integrated development environment supporting specification acquisition and analysis, requirement-based automatic test vector ...
M.R. Blackburn, R.D. Busser
openaire   +1 more source

Image_1_Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells.tif

open access: yes, 2021
T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated ...
Inès Dufait (5813792)   +9 more
core   +1 more source

Image_2_Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells.tif

open access: yes, 2021
T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated ...
Inès Dufait (5813792)   +9 more
core   +1 more source

Image_3_Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells.tif

open access: yes, 2021
T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated ...
Inès Dufait (5813792)   +9 more
core   +1 more source

T-VEC for Cancer Therapy: Applications, Limitations, and Potentials

open access: yesHighlights in Science, Engineering and Technology, 2022
Cancer is a great threat to human health, and immunotherapy has become an important means to treat cancer in recent years. Talimogene laherparepvec (T-VEC), as an oncolytic virus, is one of the immunotherapy for melanoma. This article explains its mechanism, and then summarizes its clinical applications, including the effects and safety of monotherapy ...
openaire   +1 more source

Optimal strong approximation for quadrics over $\mathbb{F}_q[t]$ [PDF]

open access: yes, 2022
Suppose $q$ is a fixed odd prime power, $F(\vec{x})$ is a non-degenerate quadratic form over $\mathbb{F}_q[t]$ of discriminant $\Delta$ in $d\geq 5$ variables $\vec{x}$, and $f,g\in\mathbb{F}_q[t]$, $\boldsymbol{\lambda}\in\mathbb{F}_q[t]^d$.
Zargar, Masoud, Sardari, Naser T.
core  

Home - About - Disclaimer - Privacy